Respiratory Medicine
Volume 101, Issue 5 , Pages 977-982, May 2007

Changes in pulmonary function in patients with ulcerative colitis

  • Aliaë A.R. Mohamed-Hussein

      Affiliations

    • Department of Chest, Assiut University Hospitals, Egypt
    • Corresponding Author InformationCorresponding author. Tel.: +202882324676; fax: +2022313344.
  • ,
  • Nadia A.S. Mohamed

      Affiliations

    • Departments of Tropical Medicine and Gastroenterology, Assiut University Hospitals, Egypt
  • ,
  • Mohamed-Eltaher A.R. Ibrahim

      Affiliations

    • Departments of Tropical Medicine and Gastroenterology, Assiut University Hospitals, Egypt

Received 11 April 2006; accepted 5 September 2006. published online 20 October 2006.

Summary 

Objectives

Information on the occurrence and frequency of pulmonary involvement in patients with ulcerative colitis (UC) is inconsistent. Some authors reported pulmonary impairment with UC by standard pulmonary function tests (PFTs) and documented a reduced diffusing capacity for carbon monoxide (DLCO) especially in patients with active disease, whereas others could not detect differences in routine PFTs between UC patients and controls.

Aim

The aim of this prospective study was to determine the frequency and type of pulmonary dysfunction in patients with UC with respect to disease activity. Furthermore, to evaluate the influence of smoking, nutritional status, sputum cytology and sulphasalazine therapy on PFT parameters.

Patients and methods

Twenty-six patients with UC (20 with active disease, 6 inactive) and 16 age and sex matched healthy controls were investigated with respect to the following pulmonary function tests, forced vital capacity (FVC), forced expiratory volume in the 1s (FEV1%) and their ratio (FEV1/FVC) and forced expiratory flow 25–75% (FEF25–75%) as well as oxygen saturation. For UC patients, colonoscopy and biopsy were done. Disease activity was assessed by Truelove index for UC. Induced sputum was sampled for cytology. Smoking habit, body mass index (BMI) and medications were recorded.

Results

Fifteen out of 26 patients with UC (57.6%) exhibited at least one pathological pulmonary function test (<80% of predicted value). Small airway obstruction was reported in the 15 patients, restrictive dysfunction in 30.7% and obstructive dysfunction in 11.5%. The impairment of PFTs was significant and more pronounced in patients with active disease, FVC (−14% of predicted), FEV1 (−9% of predicted) and FEF25–75% (−32% of predicted), P<0.01, 0.05 and 0.01, respectively. There was no significant influence of smoking and medications on PFTs.

Conclusions

UC patients show significantly decreased lung function tests in comparison to healthy controls. The impairment in active disease exceeded that during the remission. Early recognition is important, as they can be strikingly steroid responsive.

Keywords: Ulcerative colitis, Pulmonary functions, Sputum lymphocytosis

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0954-6111(06)00447-1

doi:10.1016/j.rmed.2006.09.005

Respiratory Medicine
Volume 101, Issue 5 , Pages 977-982, May 2007